#National Institutes of Health

Study findings identify a potential marker that could help identify people at high risk of developing long COVID.

Mitochondrial dysfunction has been found in some people with long COVID and other conditions that include fatigue.

Funding will support research on conditions including fatty liver disease, liver cancer, asthma and chronic kidney disease.

Researchers saw the largest increases in breast cancer incidence among women who had higher particulate matter levels near their home.

NIH and CDC study finds telehealth associated with increased likelihood of receiving evidence-based standard of care.

NIH-funded research links alterations to inflammatory protein, underscores vaccine importance.

Antibodies crossed the placenta, likely conferring some protection for newborns immediately after birth.

Researchers are working on vaccines that will target multiple flu or coronavirus strains.

Dr. Marrazzo is a renowned HIV and STI expert at the University of Alabama Birmingham.

The first studies, launched on July 31, will focus on viral persistence and cognitive dysfunction.

Researchers are working on a cure for hepatitis B and a vaccine and long-acting antivirals for hepatitis C.

NIH study finds radiation shows strongest association with aging, less for surgery and endocrine treatments.

REPRIEVE trial finds pitavastatin reduced the risk for heart attack, stroke and other major cardiovascular events by 35%.

A better understanding of post-Lyme syndrome may also shed light long COVID and myalgic encephalomyelitis/chronic fatigue syndrome.

Study results help explain why some cancers have different prognosis in men and women, and also suggest novel treatment strategies.

Shorter treatment is needed to curb tuberculosis, a leading killer of people living with HIV.